The Integrated AI Platform for End to End Preclinical Discovery

From target to preclinical insights on one modular, scalable system.

Platform Overview

DiscoveraAI is an integrated discovery environment that learns and generates high accuracy data across the pipeline. It unifies structural, relational and literature signals, and exposes each capability as a module you can use standalone or end to end.

High accuracy with low time to decision

using a hybrid of GNN, LLM and vector embeddings

so teams can adopt Docking, Target Prediction or Protein Structure modules independently

for emerging markets while scaling to enterprise workloads

Modular SaaS
Affordable and accessible
Why DiscoveraAI

Core Modules

Provide a short summary of your recent projects, highlighting the most important things.

DockAI:

AI enhanced molecular docking with dynamic protein flexibility, AI scoring and support for low resolution or predicted structures. Predicts orthosteric and allosteric binding sites.

DrugSim AI:

Multi source ligand and protein similarity to rapidly shortlist candidates for screening or repurposing.

DTPred AI:

Drug–target interaction prediction to discover or confirm biological targets with lower false positives.

ProteinPred:

Structure prediction via AlphaFold 2 and OmegaFold for accurate 3D models that unlock better docking.

Standard Workflow

  • Target intelligence
    Prioritise targets using DTPred AI and literature signals that highlight mechanism plausibility.

  • Structure readiness
    Generate high-confidence protein structures with ProteinPred, where experimental data is incomplete.

  • Virtual screening
    Use DrugSim AI for coarse selection, then DockAI for pose quality, affinity ranking, and site specificity.

  • Downstream analytics
    ADMET indicators, pathway enrichment, and transparent evidence reports are ready for review and export.

Competitive Edge

  • Hybrid AI with transparent score rationales and evidence trails

  • Configurable deployment: SaaS, private VPC, or on-prem

  • Zero Trust architecture with role controls, encryption, and audit logs

  • Extensible connectors and adapters for new data types and lab systems

AI Applications in Real-World Drug Discovery

Explore how DiscoveraAI accelerates innovation across therapeutic domains through intelligent prediction, modeling, and validation.

AI-Powered Oncology Discovery
Metabolic Pathway Optimization
AI-Driven Natural Compound Analysis
Neurodegenerative Disease Modeling
Precision for Rare Diseases
Advanced Skincare R&D

Frequently asked questions

What makes DiscoveraAI different from other AI tools?

It combines multiple AI models into one integrated system — reducing fragmentation and improving accuracy.

Can it integrate with existing research pipelines?

Yes, DiscoveraAI is designed to integrate seamlessly with existing pharma and biotech workflows.

Is it suitable for small biotech companies?

Yes, it is scalable and accessible for startups as well as enterprise organisations.

How accurate are the predictions?

Our models are continuously validated using experimental and real-world data.

What datasets does it support?

It supports genomic, proteomic, and clinical datasets across multiple domains.

Let’s Build The Next Breakthrough Together

Join us in advancing AI-led biotechnology and reshaping the global healthcare landscape.